ARCHIVES

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

This article is from The Cancer Letter archive.

Vol. 21 No. 17 | April 28, 1995

Download PDF Visit The Full Archive

Related Articles

DRG Regulation Opponents May Have Powerful New Ally

November 25, 1983

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

April 14, 2000

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

Contract Awards Sole Source Negotiations

January 13, 1978

Radiation Oncologist Objects To ACR Comments Results

November 27, 1981

Letter From Congress Prompts NCI To Pull Abortion Fact Sheet From Web

July 12, 2002